Ipamorelin
Also known as: IPA
Ipamorelin is a synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) originally developed by Novo Nordisk and later advanced by Helsinn/Nycomed. It is a selective ghrelin receptor agonist / growth hormone secretagogue (GHRP). Its defining feature versus older GHRPs (GHRP-2, GHRP-6, hexarelin) is that in preclinical and early clinical studies it raised GH without meaningfully increasing ACTH, cortisol, or prolactin. It is not FDA-approved for any indication; a Phase 2 trial for postoperative ileus failed to meet its primary endpoint and clinical development was discontinued. In the wellness/grey market it is sold as a research chemical and used off-label for anti-aging and body-composition goals despite no clinically validated human dose for those uses.
Who's worth your money for Ipamorelin
Every current seller, ranked by independent evidence — Merit Score, latest COA purity, and live $/mg (size-normalized). Prices refresh daily. Rankings are never paid.
Top Merit pick
Highest Merit Score (99) of 37 scored sellers
$51.99 · 10mg · 99.9% purity
Best value after code
$2.34/mg effective with 10% code
$26.00 · 10mg
Most tested
65 independent COAs on file
$44.99 · 10mg · 99.7% purity
Average price
$6.39/mg
Sellers
72
45-day trend
-8.6%
52 of 72 sellers have a current price· 2 stale hidden· 13 unverified hidden
Top Merit pick
🇺🇸 Glacier Aminos99✓ verified at source · 1h ago
$5.20/mg -18.6% vs avg$51.99
10mg
- 🇺🇸 Peptide Partners99
✓ verified at source · 3d ago
$8.20/mg +28.4% vs avg$82.00
10mg
- 🇺🇸 Moglabs98
✓ verified at source · just now
$5.60/mg -12.3% vs avg$28.00
5mg
- 🇺🇸 Hydro Research Peptides97
via Disclosed Labs · 5d ago · stale
$6.00/mg -6% vs avg$30.00
5mg
- 🇺🇸 Prime Peptides96
✓ verified at source · just now
$6.00/mg -6% vs avg$60.00
10mg
- 🇺🇸 BioLongevity Labs96
✓ verified at source · just now
$8.00/mg +25.2% vs avg$79.97
10mg
- 🇺🇸 Orbitrex Peptides95
via Disclosed Labs · 5d ago · stale
$5.00/mg -21.7% vs avg$49.99
10mg
- 🇺🇸 Profound Aminos95
✓ verified at source · 3d ago · stale
$5.50/mg -13.9% vs avg$55.00
10mg
- 🇺🇸 Sunrise Bioresearch95
✓ verified at source · just now
$19.50/mg +205.3% vs avg$195
10mg
- 🇺🇸 Peptide Crafters94
✓ verified at source · 1h ago
$5.00/mg -21.7% vs avg$50.00
10mg
Prices observed from public storefronts (last 24h), normalized to $/mg. "Evidence" is Merit's 0–100 Merit Score, derived only from observable verification evidence (methodology on /about); "Purity" is the latest independent COA. Some buy links are affiliate links — Merit may earn a commission at no extra cost to you, and where a vendor offers one, the code shown gets you a discount at their checkout. Affiliate status never affects price data, ranking, or the Merit Score (full policy on /disclosure). Research use only.
Watch Ipamorelin
Get one email when the market actually moves — no newsletter, no noise.
About Ipamorelin
CAS
170851-70-4
Molecular formula
C38H49N9O5
Typical dose range
100–300 mcg per injection subcutaneous, typically 1–3x daily in research use
Half-life
~2 hours
COAs for Ipamorelin
291 third-party tests across 45 vendors. Each card links to the full report.
For
Ipamorelin
by VoriLabs· batch IPA-M2609-B
For
Ipamorelin
by VoriLabs· batch IPA-A2609-C
For
Ipamorelin
by Riptide Wellness· batch RWIPA-10-1003
For
Ipamorelin
by Sunrise Bioresearch· batch IPA10SEP26-01
For
Ipamorelin
by Sunrise Bioresearch· batch IPA10SEP26-01
For
Ipamorelin
by Peptide Plugs· batch 710410L-DK
For
Ipamorelin
by Velora Biolabs· batch VBL-IP10-1
For
Ipamorelin
by Artisan Aminos· batch AA-IP10-049
For
Ipamorelin
by Voltera Sciences· batch IP10-07082026
For
Ipamorelin
by Peptide Plugs· batch 103-10-ZB
For
Ipamorelin
by Verified Peptides· batch IPA06261210L
For
Ipamorelin
by OROS Research· batch OR-LPIPA5-626-B5
For
Ipamorelin
by VeratisBio· batch IPA260618A
For
Ipamorelin
by EZ Peptides· batch EZP-IPA1006032026-15
For
Ipamorelin
by EZ Peptides· batch EZP-IPA1006032026-15
For
Ipamorelin
by Soma Peptides· batch IPV006540-F
For
Ipamorelin
by Blank Peptides· batch B-9043831-P
For
Ipamorelin
by Peptide Partners· batch SPL-4153
For
Ipamorelin
by Peptide Partners· batch IP202606
For
Ipamorelin
by Peptide Supply Co.· batch IP10-06032026
For
Ipamorelin
by Blank Peptides· batch IPA10-062026-1
For
IPAMO
by Ion Peptide· batch IP5-05072026
For
IPAMO
by Ion Peptide· batch IP5-05072026
For
Ipamorelin/CJC-1295
by Peptide Partners· batch SPL-3789
18 citations indexed for Ipamorelin
Study · 2026
Peptide Supplements and Their Therapeutic Applications in Sports Medicine
Background The peptide supplement market has experienced rapid growth due to marketing claims of enhanced performance and accelerated recovery from musculoskeletal injury.
review · 2026
The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration
Performance-enhancing drugs (PEDs) marketed as "research compounds" include unregulated peptides intended to modulate the growth hormone-insulin-like growth factor-1 (GH-IGF-1) axis.
Study · 2026
Growth Hormone-Releasing Peptides: Investigation of Their Secondary Structure, Thermal Stability, and Model Membrane Interactions
Growth hormone-releasing peptides (GHRPs) comprise a group of small synthetic peptides that can effectively influence growth hormone secretion both in humans and animals.
review · 2026
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
Background Peptide therapeutics represent an emerging frontier in gerontological medicine, targeting fundamental hallmarks of aging including metabolic dysfunction, telomere attrition, tissue repair impairment, and hormonal decline.
review · 2026
Dangers of Injectable Peptides and Other Unregulated "Biohacking" Drugs
Injectable peptides are increasingly used without prescriptions for cosmetic and athletic enhancement, driven by digital marketing and social media.
review · 2026
Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review
Introduction Peptide-based therapies are increasingly used in urology and sexual medicine, although adoption is often influenced by off-label prescribing, direct-to-consumer promotion, and limited long-term safety data. We review mechanisms, clinical evidence, dosing, safety, and regulatory status of these agents.